Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05991908
What this trial is testing

Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Shanghai Jiao Tong University School of Medicine 222
Large-scale testing (Phase 3)Study completedNCT02678572
What this trial is testing

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Who this might be right for
Ocular MelanomaUveal Melanoma
Delcath Systems Inc. 102
Testing effectiveness (Phase 2)Study completedNCT00427765
What this trial is testing

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma
M.D. Anderson Cancer Center 168
Testing effectiveness (Phase 2)Ended earlyNCT00637767
What this trial is testing

High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Southampton 25
Testing effectiveness (Phase 2)Study completedNCT00002601
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma

Who this might be right for
Sarcoma
City of Hope Medical Center 13
Large-scale testing (Phase 3)Enrolling By InvitationNCT05674539
What this trial is testing

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia, AdultMyelodysplastic Syndrome(MDS)Allogeneic Hematopoietic Stem Cell Transplantation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200
Testing effectiveness (Phase 2)Study completedNCT00506129
What this trial is testing

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
LymphomaDisorder Related to Bone Marrow Transplantation
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT00025662
What this trial is testing

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

Who this might be right for
Graft vs Host DiseaseMyelodysplastic SyndromesLeukemia+7 more
National Heart, Lung, and Blood Institute (NHLBI) 23
Large-scale testing (Phase 3)UnknownNCT03385096
What this trial is testing

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Who this might be right for
Autologous Hematopoietic Stem Cell TransplantationConditioningMultiple Myeloma
Nanfang Hospital, Southern Medical University 122
Post-approval studies (Phase 4)Study completedNCT00652041
What this trial is testing

Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 40
Testing effectiveness (Phase 2)Study completedNCT00458822
What this trial is testing

Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00320476
What this trial is testing

VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 35
Testing effectiveness (Phase 2)WithdrawnNCT00516191
What this trial is testing

A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of California, San Francisco
Testing effectiveness (Phase 2)UnknownNCT05367856
What this trial is testing

Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma

Who this might be right for
T Cell Lymphoma
Ruijin Hospital 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07774299
What this trial is testing

Pirtobrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

Who this might be right for
DLBCL
Ruijin Hospital 28
Early research (Phase 1)Study completedNCT02097134
What this trial is testing

Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma

Who this might be right for
Unilateral Retinoblastoma
Children's Oncology Group 14
Large-scale testing (Phase 3)Study completedNCT02939287
What this trial is testing

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Who this might be right for
NauseaVomiting
Rush University Medical Center 52
Early research (Phase 1)Study completedNCT01362452
What this trial is testing

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 5
Early research (Phase 1)Ended earlyNCT00052884
What this trial is testing

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganMultiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544466
What this trial is testing

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 75
Next Page